查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1978942

感冒和流感補充劑市場：按劑型、活性成分、分銷管道和最終用戶分類－2026-2032年全球市場預測

Cold & Flu Supplements Market by Form, Active Ingredient, Distribution Channel, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，感冒和流感補充劑市場價值將達到 206.8 億美元，到 2026 年將成長到 230.5 億美元，到 2032 年將達到 445.9 億美元，複合年成長率為 11.59%。

主要市場統計數據
基準年 2025 206.8億美元
預計年份：2026年 230.5億美元
預測年份 2032 445.9億美元
複合年成長率 (%) 11.59%

這篇權威的介紹概述了消費者對健康的期望、配方創新和不斷發展的銷售管道如何重塑感冒和流感補充劑的策略。

感冒和流感保健品市場已不再局限於緩解症狀，而是由消費者健康意識、成分科學和全通路零售趨勢共同塑造的複雜生態系統。消費者越來越將保健品視為預防性健康習慣的一部分，從而推動了對那些承諾增強免疫力、快速緩解症狀或在季節性疾病爆發期間提供支持的產品的需求。同時，醫療保健專業人員和監管機構要求提供更清晰的科學證據和更透明的標籤，迫使製造商在行銷宣傳和實證數據之間取得平衡。

將科學檢驗、個人化、永續性壓力和通路轉型所驅動的產業變革進行策略性整合，以重新定義競爭優勢。

近年來，顛覆性的變化重塑了競爭策略框架，並從根本上改變了產品觸及消費者的方式。成分科學的進步和對臨床檢驗的日益重視提高了產品宣稱的標準，迫使製造商投資於針對性研究和第三方檢驗。同時，個人化已從概念走向實踐，透過採用針對不同年齡層和生活方式需求的配方和劑型，打造更具針對性的價值提案。

對近期關稅變化如何推動供應鏈中的策略採購、生產調整和價格演變進行全面分析。

近期政策週期中引入的關稅環境對原料採購、生產經濟性和商業策略等各個環節都產生了實際的影響。採購團隊已採取應對措施，重新評估供應商網路，探索近岸採購方案，並協商長期合約以確保原料供應穩定。因此，配方決策正在重新評估，以平衡原料的有效性和供應穩定性。在某些情況下，企業正在選擇替代的植物性成分，並調整劑量策略，以維持獲利能力和治療效果。

將形式偏好、分銷管道、活性成分的關鍵賣點、終端用戶最佳化和價格範圍等因素連結起來，形成一個統一的策略框架，從而提供詳細的細分洞察。

了解市場區隔對於制定符合消費者偏好和分銷管道經濟效益的產品策略至關重要。以劑型分類，市場包括膠囊、軟糖、液體、粉末、噴霧劑、糖漿和片劑，每種劑型都有其獨特的生產考慮、感知益處和消費者便利性因素。給藥方式會影響其在展示中的吸引力、劑量準確性和對不同年齡層的適用性，最終影響功效聲明的構成和包裝設計。

區域洞察揭示了消費者偏好、監管細微差別和分銷成熟度如何影響全球主要地區的產品策略。

區域趨勢塑造了需求模式、供應選擇和監管預期，因此關鍵區域需要採取差異化的商業性策略。在美洲，消費者對具有增強免疫力功效的植物來源和維生素產品的需求，使得高階產品更傾向於透過零售藥局和電商通路銷售，而成本績效實惠的產品則在量販店通路中蓬勃發展。此外，該地區對經臨床驗證的功效聲明的認可度很高，這推動了對人體研究和第三方認證的投資。

競爭情報強調了整合研發、供應鏈夥伴關係和以證據為基礎的品牌建立如何決定領導地位並創造可防禦的差異化優勢。

競爭格局的動態體現了品牌股權、卓越製造能力以及滿足不斷變化的科學和監管要求的能力之間的平衡。主要企業正在整合研發、品質保證和供應鏈等各個環節的能力，以加快檢驗創新產品的上市速度。與原料供應商、臨床研究機構和專業契約製造製造商建立策略合作夥伴關係，使企業能夠在不偏離核心業務的前提下，擴大複雜產品形式和植物萃取物的生產規模。

為高階主管提供可操作的策略重點，以確保供應彈性、驗證產品功效、最佳化銷售管道並增強消費者信心。

行業領導企業應優先考慮一系列合作舉措，以降低風險並抓住機會。首先，應實現採購管道多元化，並對替代供應商進行認證，以減輕地緣政治因素和關稅相關干擾的影響。此外，還應增加對供應商審核和批次級可追溯性的投入，以確保業務連續性和良好的聲譽。其次，應加快對臨床檢驗和第三方檢測的投資，以支持產品宣稱並建立消費者和通路合作夥伴的信任。這將有助於產品定位高階市場並獲得藥房上架。

研究途徑透明的混合方法，結合專家訪談、消費者調查、分銷管道審核和供應鏈檢驗，以檢驗策略洞察。

本研究採用混合方法進行綜合分析，旨在交叉檢驗商業性訊號和科學證據。關鍵的定性資料包括對產品開發人員、法規遵循專家、採購經理和零售品類經理的訪談，以揭示營運限制和上市時間優先事項。此外，也進行了結構化的消費者調查，探討不同生命階段族群的使用模式、產品形態偏好和購買因素，補充了這些觀點。

簡潔的結論強調，科學檢驗、精確細分和強力的商業化策略結合是該領域成功的關鍵。

總而言之，感冒和流感保健品市場需要採取多管齊下的策略，將科學可信度、精準的市場細分以及兼顧銷售管道的產品開發相結合。產品劑型和活性成分必須根據終端用戶需求和銷售管道限制進行精心調整。同時，持續投入科學證據和提高透明度對於滿足監管審查和不斷變化的消費者期望至關重要。供應鏈的韌性和定價策略對於應對成本壓力和複雜的地緣政治環境仍然至關重要。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：感冒和流感補充劑市場：按劑型分類

  • 膠囊
  • 軟糖
  • 液體
  • 粉末
  • 噴
  • 糖漿
  • 藥片

第9章：按活性成分分類的感冒和流感補充劑市場

  • 草藥萃取物
    • 安德羅皮斯
    • 紫錐花
    • 接骨木
  • 綜合維他命
  • 益生菌
  • 維生素C
  • 鋅

第10章：感冒和流感補充劑市場：按分銷管道分類

  • 便利商店
  • 線上
    • 品牌官方網站
    • 消費者
    • EC平台
  • 零售藥房
  • 超級市場和大賣場

第11章：感冒和流感補充劑市場：按最終用戶分類

  • 成人
  • 孩子
  • 老年人

第12章：感冒和流感補充劑市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章：感冒與流感補充品市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：感冒和流感補充劑市場：按國家/地區分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國感冒和流感補充劑市場

第16章：中國感冒和流感保健品市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Amway International Inc.
  • Bayer AG
  • Church & Dwight Co., Inc.
  • GlaxoSmithKline PLC
  • Haleon PLC
  • Himalaya Global Holdings Ltd.
  • Johnson & Johnson Services Inc.
  • Medique Products
  • Mondelez Global LLC
  • Nature's Sunshine Products, Inc.
  • Nature's Way, Inc.
  • Neurobiologix, Inc.
  • Nutraceutical Corporation
  • Perrigo Company PLC
  • Reckitt Benckiser Group PLC
  • Sambucol by PharmaCare Laboratories Pty Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • The Menarini Group
  • The Procter & Gamble Company
  • Thornton and Ross Limited by STADA Group
  • Wakunaga Pharmaceutical Co., Ltd.
Product Code: MRR-521BAA36EA80

The Cold & Flu Supplements Market was valued at USD 20.68 billion in 2025 and is projected to grow to USD 23.05 billion in 2026, with a CAGR of 11.59%, reaching USD 44.59 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 20.68 billion
Estimated Year [2026] USD 23.05 billion
Forecast Year [2032] USD 44.59 billion
CAGR (%) 11.59%

An authoritative introduction that frames how consumer health expectations, formulation innovation, and channel evolution are reshaping cold and flu supplement strategies

The cold and flu supplements landscape has evolved beyond simple symptomatic relief into a complex ecosystem shaped by consumer health consciousness, ingredient science, and omnichannel retail dynamics. Increasingly, consumers treat supplementation as part of preventive health routines, driving demand for products that promise immune resilience, rapid relief, or support during seasonal outbreaks. At the same time, healthcare professionals and regulators expect clearer evidence and transparent labeling, prompting manufacturers to balance marketing claims with substantiation.

Simultaneously, product innovation has diversified the palette of delivery formats and active compounds, enabling brands to target distinct consumer preferences and life stages. Digital engagement has become central to discovery and purchase, with brand storytelling, peer reviews, and direct-to-consumer experiences influencing buying decisions. Supply chain complexity and rising input costs require manufacturers to reassess sourcing, formulation, and cost-to-serve models. As a result, market participants face the dual imperative of accelerating innovation while strengthening product integrity and commercial agility.

This report aims to illuminate these dynamics and provide practical perspectives for leaders seeking to refine product portfolios, channel strategies, and operational resilience. It synthesizes cross-disciplinary signals to highlight where competitive advantage is emerging and where strategic investment will yield the greatest returns in consumer trust and business performance.

A strategic synthesis of the industry shifts driven by scientific validation, personalization, sustainability pressure, and channel transformation that redefine competitive advantage

Recent years have produced transformative shifts that have redefined competitive playbooks and reshaped how products reach consumers. Advances in ingredient science and a stronger emphasis on clinical validation have elevated the bar for product claims, prompting manufacturers to invest in targeted studies and third-party verification. At the same time, personalization has moved from concept to practice, with formulations and formats tailored to age cohorts and lifestyle needs, resulting in more focused value propositions.

Meanwhile, distribution paradigms have shifted as digital channels matured; direct-to-consumer models coexist with traditional pharmacy and grocery placements, creating new pathways for customer acquisition and data-driven loyalty. Sustainability and ethical sourcing have emerged as decision criteria for discerning buyers, influencing packaging choices and supplier relationships. Additionally, heightened scrutiny from regulators and retailers has accelerated the adoption of quality management systems and transparent labeling practices.

Consequently, companies that integrate robust evidence, nimble channel strategies, and clear sustainability commitments are gaining traction. These shifts demand cross-functional coordination-research and development, regulatory affairs, marketing, and supply chain must collaborate to convert scientific credibility into compelling market propositions and long-term consumer trust.

A comprehensive analysis of how recent tariff shifts have prompted strategic sourcing, manufacturing adjustments, and pricing evolution across the supply chain

The tariff landscape introduced in recent policymaking cycles has created tangible downstream effects across ingredient sourcing, manufacturing economics, and commercial strategy. Procurement teams have responded by reassessing supplier networks, seeking nearshore options, and negotiating longer-term contracts to stabilize input flows. Consequently, formulation decisions are being revisited to balance ingredient efficacy with supply security; in some cases, this has led to alternative botanical selections or modified dosage strategies to preserve margin and maintain therapeutic intent.

From an operational perspective, manufacturers have prioritized inventory optimization and flexible production scheduling to absorb cost volatility. Contract manufacturers and private-label partners play an increasingly strategic role, offering capacity buffers and localized production that mitigate cross-border tariff exposure. Parallel to these changes, pricing strategies have become more nuanced: many firms are segmenting offerings between value-oriented lines and premium propositions, while employing trade promotions and loyalty incentives to preserve consumer accessibility.

In regulatory and compliance terms, tariff-driven supply shifts have amplified the need for rigorous supplier auditing and traceability. Companies are enhancing documentation and testing protocols to ensure continuity of supply and maintain retailer requirements. Overall, the cumulative impact of tariffs has accelerated structural adjustments across the value chain, incentivizing resilience-focused investments and closer collaboration between procurement, R&D, and commercial teams.

Deep segmentation insights linking format preferences, distribution channels, active ingredient narratives, end-user tailoring, and pricing tiers into a unified strategic framework

Understanding segmentation is essential for designing product strategies that align with consumer preferences and channel economics. Based on form, the market includes capsules, gummies, liquid, powder, spray, syrup, and tablets, each of which presents distinct manufacturing considerations, perceived benefits, and consumer convenience factors. Delivery format influences shelf appeal, dosing precision, and suitability for different age cohorts, which in turn shape claims architecture and packaging design.

Based on distribution channel, the landscape spans convenience stores, online, retail pharmacies, and supermarkets hypermarkets, with online activity further split across brand websites, direct-to-consumer channels, and e-commerce platforms. Channel selection dictates assortment depth, promotional cadence, and data capture capabilities, and it affects margins and fulfillment models. For example, direct-to-consumer channels facilitate richer consumer engagement and higher lifetime value potential, while retail pharmacies often prioritize clinical credibility and stock-turn efficiency.

Based on active ingredient, manufacturers work with herbal extracts, multivitamin complexes, probiotics, vitamin C, and zinc; within herbal extracts, specific botanicals like andrographis, echinacea, and elderberry carry unique cultural and scientific narratives that influence consumer trust. Each active ingredient category requires tailored sourcing, stability testing, and substantiation pathways. Based on end user, segmentation across adults, children, and elderly calls for formulation, dosing, and flavor considerations that reduce barriers to adherence and improve safety profiles. Finally, based on price tier, mass market and premium positioning demand different brand messaging, ingredient sourcing levels, and packaging finishes that align consumer expectations with value propositions.

Taken together, these segmentation lenses offer a roadmap for product prioritization: form and ingredient choices must be coordinated with channel strategies and end-user needs, while pricing tiers should reflect both cost structures and perceived benefit.

Region-specific intelligence revealing how consumer preferences, regulatory nuances, and distribution maturity shape product strategies across major global territories

Regional dynamics shape demand patterns, supply choices, and regulatory expectations, requiring differentiated commercial approaches across key territories. In the Americas, consumer interest in immune-supporting botanicals and vitamin-led solutions tends to favor retail pharmacy placements and e-commerce for premium lines, while value-oriented formats find traction in mass retail channels. This region also demonstrates a pronounced openness to clinically backed claims, driving investment in human studies and third-party endorsements.

Across Europe Middle East & Africa, regulatory frameworks and labeling conventions vary widely, which influences ingredient acceptance and product positioning. Traditional herbal remedies coexist with evidence-driven supplements, creating opportunities for formulations that blend cultural trust with modern validation. Retail structures in this region include strong pharmacy networks and consolidated supermarket channels, and omnichannel strategies that combine in-store trust with digital convenience perform well.

Asia-Pacific presents a multifaceted landscape where traditional botanical knowledge interplays with rapid e-commerce growth and strong manufacturing capacity. Consumers often show affinity for regionally recognized herbs such as andrographis, and distribution is diverse, encompassing modern trade, specialized health retailers, and high-velocity online marketplaces. Across regions, local regulatory nuance, consumer preference for natural or clinically validated products, and the maturity of distribution ecosystems determine how brands prioritize product development and go-to-market investments.

Competitive intelligence highlighting how integrated R&D, supply chain partnerships, and evidence-driven branding determine leadership and create defensible differentiation

Competitive dynamics reflect a balance between brand equity, manufacturing excellence, and the ability to respond to evolving scientific and regulatory expectations. Leading players are consolidating capabilities across R&D, quality assurance, and supply chain to shorten time-to-market for validated innovations. Strategic partnerships with ingredient suppliers, clinical research organizations, and specialized contract manufacturers enable firms to scale complex formats and botanical extractions without diluting focus.

In parallel, smaller specialists and challenger brands carve niches through focused clinical narratives, targeted digital marketing, and community-driven engagement. These firms often leverage agility to trial novel formulations and rapid consumer feedback loops, whereas established companies invest in large-scale validation and broad distribution. Across the competitive set, differentiation increasingly hinges on traceability, ingredient transparency, and demonstrable safety and efficacy.

Additionally, retailers and wholesalers exercise growing influence by setting assortment standards and quality thresholds. Collaborative product development agreements and exclusive format launches are common strategies to secure shelf space and consumer visibility. Ultimately, market leaders combine evidence-based product development, disciplined quality systems, and channel-tailored commercial models to sustain growth and defend margin.

Actionable strategic priorities for executives to secure supply resilience, substantiate product claims, optimize channels, and strengthen consumer trust

Industry leaders should prioritize a coordinated set of actions to capture opportunity while mitigating risk. First, diversify sourcing and qualify alternate suppliers to reduce exposure to geopolitical and tariff-related disruptions; invest in robust supplier auditing and batch-level traceability to preserve continuity and reputational integrity. Second, accelerate investments in clinical validation and third-party testing to substantiate claims and build trust with both consumers and channel partners; this will support premium positioning and pharmacy listings.

Third, align portfolio architecture with channel economics by offering format variants that match consumer touchpoints-from convenient single-dose formats for convenience retail to value-driven multipacks for supermarkets, coupled with subscription-friendly configurations for direct-to-consumer channels. Fourth, adopt dynamic pricing and promotional strategies that protect margin while preserving accessibility, using data from e-commerce and retail partners to inform segmentation.

Fifth, enhance digital capabilities to capture first-party data and personalize engagement through content, sampling programs, and adherence tools. Sixth, commit to sustainable packaging and ethical ingredient sourcing, which increasingly influence retailer selection and consumer loyalty. Finally, invest in cross-functional governance that coordinates R&D, regulatory, and commercial teams to accelerate product launches and ensure compliance. Together, these actions create a resilient and consumer-centric operating model.

A transparent mixed-methods research approach combining expert interviews, consumer studies, channel audits, and supply chain verification to validate strategic insights

The research synthesis relies on a mixed-methods approach designed to triangulate commercial signals and scientific evidence. Primary qualitative inputs include expert interviews with product developers, regulatory affairs professionals, procurement leaders, and retail category managers to surface operational constraints and go-to-market priorities. These perspectives are complemented by structured consumer studies that explore usage patterns, format preferences, and purchase drivers across life-stage cohorts.

Quantitative data collection encompasses channel audits, e-commerce behavior tracking, and SKU-level assortment analysis to reveal distribution dynamics and promotional behaviours. Ingredient supply chain mapping and supplier audits provide provenance insights, while stability and formulation testing support assessments of manufacturability across forms. Regulatory and patent landscape reviews identify evolving compliance risks and intellectual property considerations.

All data streams undergo rigorous validation and cross-checking to mitigate bias. Findings are synthesized through cross-functional workshops and subjected to scenario testing to evaluate strategic implications. The methodology emphasizes transparency and replicability, enabling stakeholders to understand the evidence base behind recommendations and to apply the insights to their specific commercial contexts.

A concise conclusion emphasizing the strategic imperative to combine scientific validation, segmentation precision, and resilient commercialization to win in the sector

In summary, the cold and flu supplements arena demands a multidimensional response that integrates scientific credibility, precise segmentation, and channel-aware commercialization. Product formats and active ingredients must be carefully matched to end-user needs and channel constraints, while regulatory scrutiny and evolving consumer expectations require sustained investment in evidence and transparency. Supply chain resilience and pricing discipline remain critical to navigating cost pressures and geopolitical complexity.

Leaders that combine rigorous validation, agile distribution strategies, and clear sustainability commitments will be best positioned to build enduring brands and capture premium placements. Meanwhile, challenger brands can exploit agility and digital engagement to establish niche footholds and accelerate consumer adoption. Ultimately, the path to differentiation lies in the coherent execution of product, evidence, and commercial strategies that together foster trust and repeat purchase.

For organizations preparing their next strategic cycle, the priorities are clear: secure ingredient integrity, demonstrate claims through appropriate validation, align formats to channels and life-stage needs, and deploy data-driven commercial tactics that sustain both growth and consumer confidence.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Cold & Flu Supplements Market, by Form

  • 8.1. Capsules
  • 8.2. Gummies
  • 8.3. Liquid
  • 8.4. Powder
  • 8.5. Spray
  • 8.6. Syrup
  • 8.7. Tablets

9. Cold & Flu Supplements Market, by Active Ingredient

  • 9.1. Herbal Extracts
    • 9.1.1. Andrographis
    • 9.1.2. Echinacea
    • 9.1.3. Elderberry
  • 9.2. Multivitamin
  • 9.3. Probiotics
  • 9.4. Vitamin C
  • 9.5. Zinc

10. Cold & Flu Supplements Market, by Distribution Channel

  • 10.1. Convenience Stores
  • 10.2. Online
    • 10.2.1. Brand Website
    • 10.2.2. Direct To Consumer
    • 10.2.3. E Commerce Platform
  • 10.3. Retail Pharmacies
  • 10.4. Supermarkets Hypermarkets

11. Cold & Flu Supplements Market, by End User

  • 11.1. Adults
  • 11.2. Children
  • 11.3. Elderly

12. Cold & Flu Supplements Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Cold & Flu Supplements Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Cold & Flu Supplements Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Cold & Flu Supplements Market

16. China Cold & Flu Supplements Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Amway International Inc.
  • 17.6. Bayer AG
  • 17.7. Church & Dwight Co., Inc.
  • 17.8. GlaxoSmithKline PLC
  • 17.9. Haleon PLC
  • 17.10. Himalaya Global Holdings Ltd.
  • 17.11. Johnson & Johnson Services Inc.
  • 17.12. Medique Products
  • 17.13. Mondelez Global LLC
  • 17.14. Nature's Sunshine Products, Inc.
  • 17.15. Nature's Way, Inc.
  • 17.16. Neurobiologix, Inc.
  • 17.17. Nutraceutical Corporation
  • 17.18. Perrigo Company PLC
  • 17.19. Reckitt Benckiser Group PLC
  • 17.20. Sambucol by PharmaCare Laboratories Pty Ltd.
  • 17.21. Sun Pharmaceutical Industries Ltd.
  • 17.22. The Menarini Group
  • 17.23. The Procter & Gamble Company
  • 17.24. Thornton and Ross Limited by STADA Group
  • 17.25. Wakunaga Pharmaceutical Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL COLD & FLU SUPPLEMENTS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL COLD & FLU SUPPLEMENTS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY ACTIVE INGREDIENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES COLD & FLU SUPPLEMENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA COLD & FLU SUPPLEMENTS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY CAPSULES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY CAPSULES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY GUMMIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY GUMMIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY GUMMIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY LIQUID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY LIQUID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY POWDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY POWDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY SPRAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY SPRAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY SPRAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY SYRUP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY SYRUP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY SYRUP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY TABLETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY TABLETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY TABLETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY HERBAL EXTRACTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY HERBAL EXTRACTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY HERBAL EXTRACTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY ANDROGRAPHIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY ANDROGRAPHIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY ANDROGRAPHIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY ECHINACEA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY ECHINACEA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY ECHINACEA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY ELDERBERRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY ELDERBERRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY ELDERBERRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY MULTIVITAMIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY MULTIVITAMIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY MULTIVITAMIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY PROBIOTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY PROBIOTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY PROBIOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY VITAMIN C, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY VITAMIN C, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY VITAMIN C, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY ZINC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY ZINC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY ZINC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY CONVENIENCE STORES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY CONVENIENCE STORES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY CONVENIENCE STORES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY BRAND WEBSITE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY BRAND WEBSITE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY BRAND WEBSITE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY DIRECT TO CONSUMER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY DIRECT TO CONSUMER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY DIRECT TO CONSUMER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY E COMMERCE PLATFORM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY E COMMERCE PLATFORM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY E COMMERCE PLATFORM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY SUPERMARKETS HYPERMARKETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY SUPERMARKETS HYPERMARKETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY SUPERMARKETS HYPERMARKETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY ADULTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY ADULTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY ADULTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY CHILDREN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY CHILDREN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY CHILDREN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY ELDERLY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY ELDERLY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY ELDERLY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS COLD & FLU SUPPLEMENTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS COLD & FLU SUPPLEMENTS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS COLD & FLU SUPPLEMENTS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS COLD & FLU SUPPLEMENTS MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS COLD & FLU SUPPLEMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA COLD & FLU SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA COLD & FLU SUPPLEMENTS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA COLD & FLU SUPPLEMENTS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA COLD & FLU SUPPLEMENTS MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA COLD & FLU SUPPLEMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA COLD & FLU SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA COLD & FLU SUPPLEMENTS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA COLD & FLU SUPPLEMENTS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA COLD & FLU SUPPLEMENTS MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA COLD & FLU SUPPLEMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA COLD & FLU SUPPLEMENTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA COLD & FLU SUPPLEMENTS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA COLD & FLU SUPPLEMENTS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA COLD & FLU SUPPLEMENTS MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA COLD & FLU SUPPLEMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE COLD & FLU SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE COLD & FLU SUPPLEMENTS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE COLD & FLU SUPPLEMENTS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE COLD & FLU SUPPLEMENTS MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE COLD & FLU SUPPLEMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST COLD & FLU SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 121. MIDDLE EAST COLD & FLU SUPPLEMENTS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST COLD & FLU SUPPLEMENTS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2032 (USD MILLION)
  • TABLE 123. MIDDLE EAST COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 124. MIDDLE EAST COLD & FLU SUPPLEMENTS MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 125. MIDDLE EAST COLD & FLU SUPPLEMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. AFRICA COLD & FLU SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA COLD & FLU SUPPLEMENTS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 129. AFRICA COLD & FLU SUPPLEMENTS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2032 (USD MILLION)
  • TABLE 130. AFRICA COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 131. AFRICA COLD & FLU SUPPLEMENTS MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 132. AFRICA COLD & FLU SUPPLEMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC COLD & FLU SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC COLD & FLU SUPPLEMENTS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC COLD & FLU SUPPLEMENTS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2032 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC COLD & FLU SUPPLEMENTS MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC COLD & FLU SUPPLEMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN COLD & FLU SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 143. ASEAN COLD & FLU SUPPLEMENTS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 144. ASEAN COLD & FLU SUPPLEMENTS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2032 (USD MILLION)
  • TABLE 145. ASEAN COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 146. ASEAN COLD & FLU SUPPLEMENTS MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 147. ASEAN COLD & FLU SUPPLEMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. GCC COLD & FLU SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. GCC COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 150. GCC COLD & FLU SUPPLEMENTS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 151. GCC COLD & FLU SUPPLEMENTS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2032 (USD MILLION)
  • TABLE 152. GCC COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 153. GCC COLD & FLU SUPPLEMENTS MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 154. GCC COLD & FLU SUPPLEMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION COLD & FLU SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPEAN UNION COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPEAN UNION COLD & FLU SUPPLEMENTS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION COLD & FLU SUPPLEMENTS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPEAN UNION COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPEAN UNION COLD & FLU SUPPLEMENTS MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPEAN UNION COLD & FLU SUPPLEMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. BRICS COLD & FLU SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. BRICS COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 164. BRICS COLD & FLU SUPPLEMENTS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS COLD & FLU SUPPLEMENTS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2032 (USD MILLION)
  • TABLE 166. BRICS COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 167. BRICS COLD & FLU SUPPLEMENTS MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 168. BRICS COLD & FLU SUPPLEMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 169. G7 COLD & FLU SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 170. G7 COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 171. G7 COLD & FLU SUPPLEMENTS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 172. G7 COLD & FLU SUPPLEMENTS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2032 (USD MILLION)
  • TABLE 173. G7 COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 174. G7 COLD & FLU SUPPLEMENTS MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 175. G7 COLD & FLU SUPPLEMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. NATO COLD & FLU SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. NATO COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 178. NATO COLD & FLU SUPPLEMENTS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 179. NATO COLD & FLU SUPPLEMENTS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2032 (USD MILLION)
  • TABLE 180. NATO COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 181. NATO COLD & FLU SUPPLEMENTS MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 182. NATO COLD & FLU SUPPLEMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 183. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. UNITED STATES COLD & FLU SUPPLEMENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 185. UNITED STATES COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 186. UNITED STATES COLD & FLU SUPPLEMENTS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 187. UNITED STATES COLD & FLU SUPPLEMENTS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2032 (USD MILLION)
  • TABLE 188. UNITED STATES COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 189. UNITED STATES COLD & FLU SUPPLEMENTS MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 190. UNITED STATES COLD & FLU SUPPLEMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. CHINA COLD & FLU SUPPLEMENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 192. CHINA COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 193. CHINA COLD & FLU SUPPLEMENTS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
  • TABLE 194. CHINA COLD & FLU SUPPLEMENTS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2032 (USD MILLION)
  • TABLE 195. CHINA COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 196. CHINA COLD & FLU SUPPLEMENTS MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 197. CHINA COLD & FLU SUPPLEMENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)